<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://www.pharmanow.live/latest-news/worlds-biggest-microbiology-ccs-summit-pharmig-india-2026-unites-global-microbiology-ccs-leaders-in-hyderabad</loc>
    <lastmod>2026-10-27T19:48:53+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-27T19:48:39+05:30</news:publication_date>
      <news:title>World's Biggest Microbiology &amp; CCS Summit ‘Pharmig India 2026’ Unites Global Microbiology &amp; CCS Leaders in Hyderabad</news:title>
      <news:keywords>Pharmig India 2026, microbiology summit India, contamination control strategy summit, pharmaceutical microbiology conference, Pharmig Hyderabad 2026</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/pharmig_india_2026_hyderabad_website_press_release20261027194806.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/zyduss-moraiya-plant-closes-fda-inspection-with-5-observations</loc>
    <lastmod>2026-10-27T07:47:24+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-16T00:00:00+05:30</news:publication_date>
      <news:title>Zydus's Moraiya plant closes FDA inspection with 5 observations</news:title>
      <news:keywords>FDA Inspection, Zydus Lifesciences, Warning Letter, 483 Form</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/moraiyafact-01-jpg20261027071220.jpg</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/pfizer-fda-approval-talazoparib-enzalutamide-hrr-mutated-mapms-prostate-cancer</loc>
    <lastmod>2026-10-27T07:46:01+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-27T00:00:00+05:30</news:publication_date>
      <news:title>Pfizer Gains FDA Approval for Talazoparib Plus Enzalutamide in HRR-Mutated mAPMN/S Prostate Cancer</news:title>
      <news:keywords>talazoparib,  Prostate Cancer, Pfizer</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/Pfizer_HQ_Entrance_1600X900_opt20261027074057.jpg</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/hepion-pharmaceuticals-fda-feedback-gv104-fentanyl-prophylaxis-nda</loc>
    <lastmod>2026-10-27T10:49:22+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-26T00:00:00+05:30</news:publication_date>
      <news:title>Hepion Pharmaceuticals Gains FDA Backing for GV104 Modeling</news:title>
      <news:keywords>Hepion</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/hepion-gv104-fda-feedback-fentanyl-prophylaxis-modeling-202620261027104648.webp</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-extends-coral-snake-antivenin-lot-cl6814-expiration-june-2026</loc>
    <lastmod>2026-10-27T10:44:56+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-26T00:00:00+05:30</news:publication_date>
      <news:title>FDA Extends Coral Snake Antivenin Lot CL6814 to December 2026</news:title>
      <news:keywords>FDA</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fda-coral-snake-antivenin-lot-cl6814-expiration-extension-december-202620261027104003.webp</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/orchid-pharma-signs-80m-latin-america-deal-exblifep-nine-markets</loc>
    <lastmod>2026-10-27T10:29:57+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-26T00:00:00+05:30</news:publication_date>
      <news:title>Orchid Pharma Signs $80M Exblifep Deal Across Nine Markets</news:title>
      <news:keywords>Orchid</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/orchid-pharma-exblifep-80m-latin-america-deal-nine-markets-202620261027102735.webp</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/pfizer-25-valent-pneumococcal-vaccine-phase-2-results-infants</loc>
    <lastmod>2026-10-27T10:20:45+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-26T00:00:00+05:30</news:publication_date>
      <news:title>Pfizer Reports Positive Phase 2 Data for 25-Valent Infant Vaccine</news:title>
      <news:keywords>Pfizer</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/pfizer-25-valent-pneumococcal-vaccine-phase-2-infant-results-202620261027101902.webp</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/artelo-biosciences-art26-12-fabp5-inhibitor-mad-study-phase-1</loc>
    <lastmod>2026-10-27T10:10:44+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-26T00:00:00+05:30</news:publication_date>
      <news:title>Artelo Biosciences Advances ART26.12 Into MAD Study</news:title>
      <news:keywords>Artelo</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/artelo-art26-12-fabp5-inhibitor-phase-1-mad-study-q4-202620261027101028.webp</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/v-shapes-single-dose-packaging</loc>
    <lastmod>2026-10-26T15:25:08+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-26T00:00:00+05:30</news:publication_date>
      <news:title>V-Shapes Single-Dose Packaging for Nutraceuticals, Skincare</news:title>
      <news:keywords>V-Shapes single-dose packaging</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/v-shapes-single-dose-packaging20261026152219.webp</image:loc>
    </image:image>
  </url>
</urlset>